Capricor Therapeutics stockCAPR
Capricor Therapeutics trades at $8.60, 78.7% below its 52-week high (Dec 3, 2025). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. −70.2% year to date, +38.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 10, 2026.
Ratings, candles, signals and the screener for CAPR — after you log in
Open the terminalFrequently asked questions about Capricor Therapeutics
What is the Capricor Therapeutics stock price?
At the close on Nov 5, 2026: $8.60 (−3.59% on the day). 52-week high: $40.37 on Dec 3, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Capricor Therapeutics report earnings?
The next quarterly report is on Nov 10, 2026. Last quarter, earnings per share changed −23% year over year, revenue 0%.
Does Capricor Therapeutics pay dividends?
No, Capricor Therapeutics does not pay dividends.
Where does Capricor Therapeutics trade and how to buy it?
Ticker CAPR, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Capricor Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for CAPR are in the terminal after you log in.